TrialTrust Global Clinical Trial Document Writing & Review Services in China
Regulatory-Compliant | Authority-Ready | Globally Trusted
Who We Are
TrialTrust, the scientific arm of Zoesoe Exports Pvt. Ltd., provides end-to-end Clinical Trial (CT) Document Writing and Review Services for pharmaceutical and nutraceutical products across regulated and semi-regulated global markets.
Since 2008, we have successfully supported 330+ clinical trial documentation projects for clients across China, Asia-Pacific, Europe, the Middle East, Africa, and LATAM.
We specialize in the preparation, review, and post-submission support of Clinical Trial Protocols and Clinical Study Reports (CSRs), supported by complete scientific data, strong clinical justification, and regulatory-aligned documentation suitable for China NMPA submissions and global filings.
Our Services for Clients in China
🧪 Clinical Trial Protocol Writing
Phase I–IV, BA/BE, Pilot & Pivotal studies
Pharmaceutical & Nutraceutical products
Study design, objectives, endpoints & statistical rationale
Inclusion/exclusion criteria & risk–benefit assessment
Ethics Committee & authority-ready formats
📊 Clinical Study Report (CSR) Writing
Full Clinical Study Reports compliant with ICH E3
Data interpretation & clinical conclusions
Tables, Listings & Figures (TLFs)
Safety & efficacy evaluation
Investigator and site data integration
📁 Backup & Supporting Documentation
Investigator’s Brochure (IB)
Informed Consent Forms (ICF)
Case Report Form (CRF) review support
Statistical Analysis Plan (SAP)
Literature review & clinical justification documents
🔄 Document Review & Gap Assessment
Independent technical & regulatory review of CT documents
Gap assessment against ICH-GCP, WHO, EMA, USFDA, NMPA & ICH-China guidelines
Scientific consistency & data integrity checks
🛂 Post-Submission Query Handling
Responses to NMPA (National Medical Products Administration) & Ethics Committees
Scientific rebuttals & clarifications
Deficiency letter responses
Regulatory follow-up support until closure
Industries We Serve in China
Pharmaceutical Finished Dosage Forms
Biologics & Biosimilars
Nutraceuticals & Health Supplements
Traditional & Botanical Products
Generic & Branded Products
Export-oriented Clinical Development Programs
China & Global Regulatory Alignment
Our Clinical Trial documentation is prepared in alignment with:
ICH-GCP (E6)
ICH E3 – Clinical Study Reports
WHO Guidelines
NMPA (China)
USFDA
EMA
ICH-China implementation requirements
Country-specific Ethics Committee formats
Why Companies in China Choose TrialTrust
✅ 330+ Clinical Trial Documents Delivered Globally
✅ Experienced Clinical & Regulatory Experts
✅ Strong Pharma, Biologics & Nutraceutical Expertise
✅ Authority-Acceptable & Inspection-Ready Documentation
✅ Comprehensive Post-Submission Support
✅ Confidential, Accurate & Timeline-Driven Execution
Our Experience Footprint
330+ products supported worldwide
Clients across China, Asia-Pacific, Europe, Middle East & Africa
Expertise in NMPA submissions, bridging studies & global development programs
Support for China-only, China–global, and multinational submissions
Our Working Approach
Requirement Understanding & Scope Finalization
Regulatory Strategy & Study Design Alignment
Clinical Document Preparation / Review
Internal Scientific & Quality Review
Client Review & Finalization
Post-Submission Authority Query Handling
Confidentiality & Quality Commitment
All projects are managed under strict confidentiality agreements, supported by robust quality control, version management, and data integrity practices, ensuring regulatory confidence and global acceptance.
Contact TrialTrust in China
Looking for reliable, NMPA-aligned Clinical Trial documentation support for your pharmaceutical or nutraceutical product?
Partner with TrialTrust — where clinical science meets regulatory excellence.
📩 Contact us today to discuss your Clinical Trial documentation requirements in China.